Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutlu Doğan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 13, 2023
Gemcitabine-associated digital necrosis in metastatic breast cancerAlper Türkel, Mustafa Özdemir, Aziz Kurtuluş, et al.
Breast Cancer (Dove Medical Press)|February 26, 2026
Can We Adapt Neoadjuvant Rectal (NAR) Score with Systemic Immune-Inflammation Index (SII) and Prognostic Nutritional Index (PNI) as Prognostic Factors in Locally Advanced Breast Cancer?Cemil Yüksel, Mutlu Doğan, Serdar Çulcu, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 19, 2011
Intestinal malignant melanoma presenting with small bowel invagination: a case reportMutlu Doğan, Süleyman Ozdemır, Ethem Geçım, et al.
In Vivo (Athens, Greece)|August 28, 2025
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular CarcinomaErgin Aydemir, Funda Yilmaz, Alper Türkel, et al.
Journal of Chemotherapy (Florence, Italy)|July 28, 2025
Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challengesErgin Aydemir, Alper Türkel, Kübra Okur, et al.
BMC Women'S Health|January 31, 2025
The mediating effect of intrusive rumination on the relationship between illness uncertainty and fear of cancer recurrence in breast cancer survivorsAlper Türkel, Nur Nihal Türkel, Ahmet Kadıoğlu, et al.
Journal of Cancer Research and Therapeutics|December 17, 2020
Systemic treatment options for growing teratoma syndrome: A single-center experience with a comprehensive review of the literatureYusuf Acikgoz, Oznur Bal, Yakup Ergun, et al.
Wiener Klinische Wochenschrift|January 5, 2024
Prognostic factors in non-metastatic HER2 'low' and HER2 'negative' breast cancer: single institute experienceAlper Türkel, Mutlu Doğan, Elif Sertesen, et al.
Bosnian Journal of Basic Medical Sciences|March 9, 2017
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinomaYakup Bozkaya, Mutlu Doğan, Ozan Yazıcı, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2017
Evaluation of Lymphoma Patients Receiving High-Dose Therapy and Autologous Stem Cell Transplantation: Experience of a Single CenterYakup Bozkaya, Doğan Uncu, Simten Dağdaş, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 13, 2023
Gemcitabine-associated digital necrosis in metastatic breast cancerAlper Türkel, Mustafa Özdemir, Aziz Kurtuluş, et al.
Breast Cancer (Dove Medical Press)|February 26, 2026
Can We Adapt Neoadjuvant Rectal (NAR) Score with Systemic Immune-Inflammation Index (SII) and Prognostic Nutritional Index (PNI) as Prognostic Factors in Locally Advanced Breast Cancer?Cemil Yüksel, Mutlu Doğan, Serdar Çulcu, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 19, 2011
Intestinal malignant melanoma presenting with small bowel invagination: a case reportMutlu Doğan, Süleyman Ozdemır, Ethem Geçım, et al.
In Vivo (Athens, Greece)|August 28, 2025
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular CarcinomaErgin Aydemir, Funda Yilmaz, Alper Türkel, et al.
Journal of Chemotherapy (Florence, Italy)|July 28, 2025
Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challengesErgin Aydemir, Alper Türkel, Kübra Okur, et al.
BMC Women'S Health|January 31, 2025
The mediating effect of intrusive rumination on the relationship between illness uncertainty and fear of cancer recurrence in breast cancer survivorsAlper Türkel, Nur Nihal Türkel, Ahmet Kadıoğlu, et al.
Journal of Cancer Research and Therapeutics|December 17, 2020
Systemic treatment options for growing teratoma syndrome: A single-center experience with a comprehensive review of the literatureYusuf Acikgoz, Oznur Bal, Yakup Ergun, et al.
Wiener Klinische Wochenschrift|January 5, 2024
Prognostic factors in non-metastatic HER2 'low' and HER2 'negative' breast cancer: single institute experienceAlper Türkel, Mutlu Doğan, Elif Sertesen, et al.
Bosnian Journal of Basic Medical Sciences|March 9, 2017
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinomaYakup Bozkaya, Mutlu Doğan, Ozan Yazıcı, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2017
Evaluation of Lymphoma Patients Receiving High-Dose Therapy and Autologous Stem Cell Transplantation: Experience of a Single CenterYakup Bozkaya, Doğan Uncu, Simten Dağdaş, et al.
Pageof 3